Novo Nordisk A/S | NOVOB - Current Liabilities

Stock Price
259.95
Daily Change
13.25 5.37%
Monthly
10.24%
Yearly
-35.58%
Q2 Forecast
247.69

Novo Nordisk reported DKK215.66B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Bausch Health Companies USD 4.18B 613M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 27.28B 4.72B Dec/2025
Novo Nordisk DKK 215.66B 18.7B Dec/2025
Novo Nordisk DKK 32.79B 203.33B Jun/2025
Pacira USD 120.59M 13.51M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025